US Stock MarketDetailed Quotes

TTIPF THIOGENESIS THERAPEUTICS CORP

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)

THIOGENESIS THERAPEUTICS CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.81%-834.9K
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
Net income from continuing operations
37.71%-656.86K
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
Operating gains losses
----
----
----
----
----
----
----
----
11.94%-56.19K
-242.30%-125.67K
Other non cash items
----
----
----
----
----
----
----
----
--1.94M
--77.77K
Change In working capital
-675.30%-215.01K
-46.75%34K
-8,013.00%-1.37M
334.46%1.33M
5,114.12%1.28M
-343.98%-27.73K
108.19%63.85K
-92.34%17.26K
-212.25%-568.81K
-111.06%-25.53K
-Change in receivables
-1,502.92%-25.98K
270.53%48.06K
-127.84%-10.31K
-126.07%-29.33K
-25.26%-40.02K
4,417.07%1.85K
-51.76%-28.18K
-77.28%37.03K
167.32%112.48K
-154.89%-31.95K
-Change in prepaid assets
7,168.06%13.5K
10,943.00%22.09K
-56.48%12.79K
-10.69%-42.75K
-86.80%-72.15K
---191
--200
--29.39K
-221.34%-38.62K
---38.62K
-Change in payables and accrued expense
-589.02%-202.53K
-139.36%-36.15K
-2,683.69%-1.37M
318.73%1.41M
2,991.39%1.39M
-359.53%-29.39K
112.06%91.84K
-178.96%-49.15K
-200.10%-642.66K
-68.02%45.04K
Cash from discontinued investing activities
Operating cash flow
15.81%-834.9K
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
Investing cash flow
Cash flow from continuing investing activities
0
107.46K
-3.24M
Net business purchase and sale
----
----
----
--0
----
----
----
----
--107.46K
---3.24M
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
--107.46K
---3.24M
Financing cash flow
Cash flow from continuing financing activities
7K
0
462.5K
-49.29%4.12M
-49.80%4.12M
0
0
0
892.85%8.13M
5,475.92%8.21M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
-221.90%-175.17K
-82.60%25K
Net common stock issuance
----
----
----
-15.55%4.12M
----
----
----
----
623.16%4.88M
----
Proceeds from stock option exercised by employees
--7K
--0
--462.5K
--0
--0
--0
--0
--0
--3.42M
--3.31M
Cash from discontinued financing activities
Financing cash flow
--7K
--0
--462.5K
-49.29%4.12M
-49.80%4.12M
--0
--0
--0
892.85%8.13M
5,475.92%8.21M
Net cash flow
Beginning cash position
7.06%4.97M
3.86%5.52M
14.21%7.08M
9,805.77%6.2M
125.03%3.63M
109.57%4.64M
51.86%5.32M
9,951.69%6.2M
225.98%62.55K
2,297.75%1.61M
Current changes in cash
16.51%-827.9K
19.56%-551.12K
-75.24%-1.53M
-85.80%872.76K
-26.90%3.42M
-67.97%-991.64K
45.98%-685.15K
-126.37%-875.06K
12,094.89%6.14M
75,902.94%4.68M
Effect of exchange rate changes
124.29%4.69K
-126.98%-2.46K
-718.32%-19.03K
169.05%7.58K
119.38%20.08K
-74.59%-19.29K
148.38%9.12K
-101.90%-2.33K
-56.36%-10.98K
-818.63%-103.58K
End cash Position
14.19%4.15M
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
109.57%4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
Free cash flow
15.81%-834.9K
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.81%-834.9K19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K
Net income from continuing operations 37.71%-656.86K25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K
Operating gains losses --------------------------------11.94%-56.19K-242.30%-125.67K
Other non cash items ----------------------------------1.94M--77.77K
Change In working capital -675.30%-215.01K-46.75%34K-8,013.00%-1.37M334.46%1.33M5,114.12%1.28M-343.98%-27.73K108.19%63.85K-92.34%17.26K-212.25%-568.81K-111.06%-25.53K
-Change in receivables -1,502.92%-25.98K270.53%48.06K-127.84%-10.31K-126.07%-29.33K-25.26%-40.02K4,417.07%1.85K-51.76%-28.18K-77.28%37.03K167.32%112.48K-154.89%-31.95K
-Change in prepaid assets 7,168.06%13.5K10,943.00%22.09K-56.48%12.79K-10.69%-42.75K-86.80%-72.15K---191--200--29.39K-221.34%-38.62K---38.62K
-Change in payables and accrued expense -589.02%-202.53K-139.36%-36.15K-2,683.69%-1.37M318.73%1.41M2,991.39%1.39M-359.53%-29.39K112.06%91.84K-178.96%-49.15K-200.10%-642.66K-68.02%45.04K
Cash from discontinued investing activities
Operating cash flow 15.81%-834.9K19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K
Investing cash flow
Cash flow from continuing investing activities 0107.46K-3.24M
Net business purchase and sale --------------0------------------107.46K---3.24M
Cash from discontinued investing activities
Investing cash flow --------------0------------------107.46K---3.24M
Financing cash flow
Cash flow from continuing financing activities 7K0462.5K-49.29%4.12M-49.80%4.12M000892.85%8.13M5,475.92%8.21M
Net issuance payments of debt --------------0-----------------221.90%-175.17K-82.60%25K
Net common stock issuance -------------15.55%4.12M----------------623.16%4.88M----
Proceeds from stock option exercised by employees --7K--0--462.5K--0--0--0--0--0--3.42M--3.31M
Cash from discontinued financing activities
Financing cash flow --7K--0--462.5K-49.29%4.12M-49.80%4.12M--0--0--0892.85%8.13M5,475.92%8.21M
Net cash flow
Beginning cash position 7.06%4.97M3.86%5.52M14.21%7.08M9,805.77%6.2M125.03%3.63M109.57%4.64M51.86%5.32M9,951.69%6.2M225.98%62.55K2,297.75%1.61M
Current changes in cash 16.51%-827.9K19.56%-551.12K-75.24%-1.53M-85.80%872.76K-26.90%3.42M-67.97%-991.64K45.98%-685.15K-126.37%-875.06K12,094.89%6.14M75,902.94%4.68M
Effect of exchange rate changes 124.29%4.69K-126.98%-2.46K-718.32%-19.03K169.05%7.58K119.38%20.08K-74.59%-19.29K148.38%9.12K-101.90%-2.33K-56.36%-10.98K-818.63%-103.58K
End cash Position 14.19%4.15M7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M109.57%4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M
Free cash flow 15.81%-834.9K19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+6.16%
DexCom
DXCM
+5.57%
New Fortress Energy
NFE
+5.37%
Workday
WDAY
+2.33%
eBay
EBAY
+1.66%

Unlock the Full List